{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T13:17:03Z","timestamp":1760015823337,"version":"build-2065373602"},"reference-count":23,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.vaccine.2019.11.082","type":"journal-article","created":{"date-parts":[[2019,12,12]],"date-time":"2019-12-12T08:57:03Z","timestamp":1576141023000},"page":"1431-1435","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Measurement of surface protein antigens, PorA and PorB, in Bexsero vaccine using quantitative mass spectrometry"],"prefix":"10.1016","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4569-6972","authenticated-orcid":false,"given":"Gail","family":"Whiting","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline","family":"Vipond","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra","family":"Facchetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hannah","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun X.","family":"Wheeler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2019.11.082_b0005","doi-asserted-by":"crossref","first-page":"174","DOI":"10.4161\/hv.18500","article-title":"Bexsero: a multicomponent vaccine for prevention of meningococcal disease","volume":"82","author":"Gorringe","year":"2012","journal-title":"Hum Vaccin Immunother."},{"key":"10.1016\/j.vaccine.2019.11.082_b0010","doi-asserted-by":"crossref","first-page":"B87","DOI":"10.1016\/j.vaccine.2012.01.033","article-title":"The new multicomponent vaccine against meningococcal serogroup B, 4CMenB: immunological, functional and structural characterization of the antigens","volume":"30","author":"Serruto","year":"2012","journal-title":"Vaccine."},{"key":"10.1016\/j.vaccine.2019.11.082_b0015","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1517\/14712598.2011.585965","article-title":"Recombinant protein meningococcal serogroup B vaccine combined with outer membrane vesicles","volume":"11","author":"Bai","year":"2011","journal-title":"Expert Opin Biol Ther"},{"key":"10.1016\/j.vaccine.2019.11.082_b0020","series-title":"Meningococcal Vaccines","first-page":"81","article-title":"Outer membrane protein vesicle vaccines for meningococcal disease","author":"Frasch","year":"2001"},{"issue":"2","key":"10.1016\/j.vaccine.2019.11.082_b0025","first-page":"67","article-title":"Production, characterization and control of MenB-vaccine \u201cFolkehelsa\u201d: an outer membrane vesicle vaccine against group B meningococcal disease","volume":"14","author":"Fredriksen","year":"1991","journal-title":"NIPH Ann."},{"issue":"8","key":"10.1016\/j.vaccine.2019.11.082_b0030","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1021\/acs.jproteome.5b00938","article-title":"Neisseria meningitidis Lacking the major porins PorA and PorB is viable and modulates apoptosis and the oxidative burst of neutrophils","volume":"15","author":"Peak","year":"2016","journal-title":"J Proteome Res"},{"issue":"7","key":"10.1016\/j.vaccine.2019.11.082_b0035","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1128\/CVI.00038-06","article-title":"Understanding the immune responses to the meningococcal strain-specific vaccine MeNZB measured in studies of infants","volume":"13","author":"Ruijne","year":"2006","journal-title":"Clin Vaccine Immunol"},{"issue":"9","key":"10.1016\/j.vaccine.2019.11.082_b0040","doi-asserted-by":"crossref","first-page":"2963","DOI":"10.1128\/iai.59.9.2963-2971.1991","article-title":"Topology of outer membrane porins in pathogenic Neisseria spp","volume":"59","author":"van der Ley","year":"1991","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2019.11.082_b0045","doi-asserted-by":"crossref","first-page":"2510","DOI":"10.1016\/j.vaccine.2008.03.014","article-title":"Quantification of influenza virus hemagglutinins in complex mixtures using isotope dilution tandem mass spectrometry","volume":"26","author":"Williams","year":"2008","journal-title":"Vaccine."},{"key":"10.1016\/j.vaccine.2019.11.082_b0050","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1016\/j.vaccine.2011.12.056","article-title":"Simultaneous quantification of hemagglutinin and neuraminidase of influenza virus using isotope dilution mass spectrometry","volume":"30","author":"Williams","year":"2012","journal-title":"Vaccine."},{"key":"10.1016\/j.vaccine.2019.11.082_b0055","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/msb.2008.61","article-title":"Selected reaction monitoring for quantitative proteomics: a tutorial","volume":"4","author":"Lange","year":"2008","journal-title":"Mol Syst Biol"},{"key":"10.1016\/j.vaccine.2019.11.082_b0060","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/nmeth.2015","article-title":"Selected reaction monitoring-based proteomics: workflows, potential, pitfalls and future directions","volume":"9","author":"Picotti","year":"2012","journal-title":"Nat Methods"},{"key":"10.1016\/j.vaccine.2019.11.082_b0065","doi-asserted-by":"crossref","first-page":"2","DOI":"10.4172\/2470-1289.1000133","article-title":"Evaluation of tryptic peptides from Neisseria meningitidis outer membrane proteins PorA and PorB","volume":"6","author":"Whiting","year":"2017","journal-title":"J Proteomics Enzymol."},{"issue":"1","key":"10.1016\/j.vaccine.2019.11.082_b0070","doi-asserted-by":"crossref","first-page":"23","DOI":"10.4161\/hv.4.1.4806","article-title":"Characterization of the key antigenic components and pre-clinical immune responses to a meningococcal disease vaccine based on Neisseria lactamica outer membrane vesicles","volume":"4","author":"Finney","year":"2008","journal-title":"Hum Vaccine."},{"issue":"18","key":"10.1016\/j.vaccine.2019.11.082_b0075","doi-asserted-by":"crossref","first-page":"3211","DOI":"10.1016\/j.vaccine.2010.02.023","article-title":"Characterization of meningococcal serogroup B outer membrane vesicle vaccines from strain 44\/76 after growth in different media","volume":"28","author":"Tsolakos","year":"2010","journal-title":"Vaccine."},{"issue":"2","key":"10.1016\/j.vaccine.2019.11.082_b0080","doi-asserted-by":"crossref","first-page":"80","DOI":"10.4161\/hv.1.2.1651","article-title":"Characterization of the protein content of a meningococcal outer membrane vesicle vaccine by polyacrylamide gel electrophoresis and mass spectrometry","volume":"1","author":"Vipond","year":"2005","journal-title":"Hum Vaccine."},{"key":"10.1016\/j.vaccine.2019.11.082_b0085","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.4161\/hv.24129","article-title":"Vaccines against meningococcal serogroup B disease containing outer membrane vesicles (OMV): Lessons from past programs and implications for the future","volume":"9","author":"Holst","year":"2013","journal-title":"Human Vaccin Immunother."},{"key":"10.1016\/j.vaccine.2019.11.082_b0090","doi-asserted-by":"crossref","first-page":"6940","DOI":"10.1073\/pnas.0832254100","article-title":"Absolute quantification of proteins and phosphoproteins from cell lysates by tandem MS","volume":"100","author":"Gerber","year":"2003","journal-title":"PNAS"},{"key":"10.1016\/j.vaccine.2019.11.082_b0110","unstructured":"Electronic Medicines Compendium. Bexsero meningococcal group B vaccine for injection in pre-filled syringe. https:\/\/www.medicines.org.uk\/emc\/medicine\/28407"},{"issue":"6","key":"10.1016\/j.vaccine.2019.11.082_b0095","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.4161\/hv.28443","article-title":"Identification of peptide sequences as a measure of Anthrax vaccine stability during storage","volume":"10","author":"Whiting","year":"2014","journal-title":"Human Vaccines & Immunotherapeutics"},{"issue":"15","key":"10.1016\/j.vaccine.2019.11.082_b0100","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1016\/j.vaccine.2009.01.099","article-title":"Structural organization of NadA\u0394351-405, a recombinant MenB vaccine component, by its physico-chemical characterization at drug substance level","volume":"27","author":"Magagnoli","year":"2009","journal-title":"Vaccine."},{"issue":"7","key":"10.1016\/j.vaccine.2019.11.082_b0105","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1016\/j.vaccine.2011.12.066","article-title":"Structural characterisation, stability and antibody recognition of chimeric NHBA-GNA1030: an investigational vaccine component against Neisseria meningitidis","volume":"30","author":"Martino","year":"2012","journal-title":"Vaccine."},{"issue":"12","key":"10.1016\/j.vaccine.2019.11.082_b0115","doi-asserted-by":"crossref","first-page":"6685","DOI":"10.1128\/IAI.68.12.6685-6690.2000","article-title":"Multiple mechanisms of phase variation of PorA in Neisseria meningitidis","volume":"68","author":"van der Ende","year":"2000","journal-title":"Infect Immun"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19316366?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19316366?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:38:55Z","timestamp":1759401535000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X19316366"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":23,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["S0264410X19316366"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.11.082","relation":{},"ISSN":["0264-410X"],"issn-type":[{"type":"print","value":"0264-410X"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Measurement of surface protein antigens, PorA and PorB, in Bexsero vaccine using quantitative mass spectrometry","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.11.082","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2019 Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}